Exact Sciences Corp. (EXAS) Social Stream



Exact Sciences Corp. (EXAS): $64.97

0.85 (-1.29%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

EXACT SCIENCES CORP (EXAS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering EXACT SCIENCES CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 13 $165 $95 $143.583 $65.38 119.61%
2021-12-08 13 $163 $95 $140.25 $65.38 114.52%
2022-01-04 13 $163 $95 $139.25 $65.38 112.99%
2022-01-06 13 $163 $95 $138 $65.38 111.07%
2022-01-18 12 $163 $95 $136.5 $65.38 108.78%
2022-02-23 12 $160 $90 $130.454 $65.38 99.53%
2022-02-24 12 $160 $90 $125 $65.38 91.19%
2022-04-26 12 $160 $90 $124.09 $65.38 89.8%
2022-04-28 11 $160 $65 $104.714 $65.38 60.16%
2022-06-03 12 $160 $50 $98.4 $65.38 50.5%
2022-07-19 9 $95 $50 $79.083 $65.38 20.96%
2022-08-03 12 $95 $50 $79.083 $65.38 20.96%
2022-08-13 13 $95 $50 $71.307 $65.38 9.07%
2022-09-17 13 $95 $40 $70.538 $65.38 7.89%
2022-10-17 13 $95 $40 $69 $65.38 5.54%
2022-10-24 13 $95 $40 $69.75 $65.38 6.68%
2022-11-04 13 $85 $40 $65.363 $65.38 -0.03%
2022-11-07 13 $85 $35 $63.545 $65.38 -2.81%
2022-11-08 13 $85 $35 $62.636 $65.38 -4.2%
2022-11-14 13 $85 $35 $62 $65.38 -5.17%
2022-12-04 13 $85 $35 $61.09 $65.38 -6.56%
2022-12-15 12 $85 $35 $61.09 $65.38 -6.56%
2023-01-06 12 $85 $35 $62.545 $65.38 -4.34%
2023-01-12 12 $85 $35 $61.545 $65.38 -5.87%
2023-02-08 12 $85 $35 $63.181 $65.38 -3.36%
2023-02-21 13 $85 $35 $63.181 $65.38 -3.36%
2023-02-23 13 $92 $50 $74.166 $65.38 13.44%
2023-03-03 13 $92 $55 $75.833 $65.38 15.99%
2023-03-09 13 $92 $55 $77.5 $65.38 18.54%
2023-04-21 14 $92 $55 $76.818 $65.38 17.49%
2023-05-10 14 $92 $55 $77.333 $65.38 18.28%
2023-05-11 14 $99 $70 $84.916 $65.38 29.88%
2023-05-14 14 $99 $73 $85.75 $65.38 31.16%
2023-06-06 14 $95 $73 $87 $65.38 33.07%
2023-06-07 14 $100 $73 $88.5 $65.38 35.36%
2023-06-20 15 $120 $73 $91 $65.38 39.19%
2023-06-22 15 $130 $73 $98.666 $65.38 50.91%
2023-06-23 15 $130 $73 $103.384 $65.38 58.13%
2023-07-24 16 $130 $73 $105.5 $65.38 61.36%
2023-08-01 16 $130 $73 $105.5 $65.38 61.36%
2023-08-03 16 $130 $73 $109.357 $65.38 67.26%
2023-08-08 16 $130 $73 $110.071 $65.38 68.36%
2023-09-28 17 $130 $73 $108.266 $65.38 65.59%
2023-10-10 17 $130 $73 $108.266 $65.38 65.59%
2023-10-15 17 $130 $73 $107.6 $65.38 64.58%
2023-10-20 17 $130 $73 $106.133 $65.38 62.33%
2023-11-03 17 $130 $73 $101.266 $65.38 54.89%
2023-11-06 17 $130 $73 $100.6 $65.38 53.87%

The Trend in the Analyst Price Target


Over the past 43 months, EXAS's average price target has gone up $0.13.

EXAS reports an average of 17.95% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-23 13 92 50 74.166 61.63 20.34%
2023-03-03 13 92 55 75.833 67.51 12.33%
2023-05-15 14 95 73 87.000 80.93 7.5%
2023-06-07 15 100 73 88.500 87.76 0.84%
2023-11-03 17 130 73 102.466 67.02 52.89%

EXAS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.35 14 0 3 0 0 17

The Trend in the Broker Recommendations


Over the past 15 months, EXAS's average broker recommendation rating improved by 0.03.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • EXACT SCIENCES CORP's number of analysts covering the stock is higher than 4320.52% of all US stocks.
  • In the context of Healthcare stocks, EXACT SCIENCES CORP's average analyst price target is higher than 4560% of them.
  • EXAS has a higher upside potential (average analyst target price relative to current price) than 3472.91% of stocks in the large market cap category.
  • EXAS has a lower variance in analysts' estimates than -3892.46% of stocks in the large market cap category.

Stocks similar to EXACT SCIENCES CORP in the Business Services industry regarding analyst recommendations and price targets are CRL, INCY, and WSC.

Is EXAS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!